Journal
DERMATOLOGIC SURGERY
Volume 37, Issue 2, Pages 183-191Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1111/j.1524-4725.2010.01848.x
Keywords
-
Categories
Funding
- American Society for Dermatologic Surgery
Ask authors/readers for more resources
BACKGROUND Little is known about the possible association between nonmelanoma skin cancer (NMSC) and allograft survival and overall patient survival. OBJECTIVE To determine the association between posttransplant NMSC and early to mid-term allograft survival and overall patient survival after kidney, liver, or heart transplantation. METHODS AND MATERIALS We retrospectively reviewed patients identified from the Organ Procurement and Transplantation Network/United Network for Organ Sharing database. The study included adult recipients of kidney (n = 46,216), liver (n = 8,049), and heart (n = 8,519) transplants from 1996 to 2001. RESULTS Multivariate analysis showed that kidney recipients with NMSC had a significantly lower risk of allograft loss (relative risk (RR) = 0.55, p<.001) and death (RR = 0.55; p<.001) within 5 years of transplantation than recipients without NMSC. Significantly lower risk of death was also observed for liver recipients (RR = 0.28, p<.001) and heart recipients (RR = 0.25; p<.001) with NMSC. CONCLUSIONS Longer early to mid-term allograft and overall survival was seen in patients with NMSC, but long-term survival rates must be examined to determine whether mortality rates increase later for patients with NMSC, as noted in previous studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available